Chẩn đoán và điều trị trầm cảm sau đột quỵ

Chen C et al. The interaction between neuropsychological and motor deficits in patients after stroke. Neurology 2013; 80:S27–34 Robinson RG et al. Poststroke depression: a review. Can J Psychiatry 2010; 55:341–349 Morris PL et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993; 150:124–129 Bartoli F et al. Depression after stroke and risk of mortality: a systematic review and meta-analysis. Stroke Res Treat 2013; 2013:862978 Goldstein LB et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:517–584 Heuschmann P et al. Schlaganfallhäufigkeit und Versorgung von Schlaganfallpatienten in Deutschland. Für das Kompetenznetz Schlaganfall, die Deutsche Schlaganfall Gesellschaft sowie die Stiftung Deutsche Schlaganfall-Hilfe. Akt Neurol 2010; 37:333–340 Loubinoux I et al. Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med 2012; 16:1961–1969 Ayerbe L et al. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br J Psychiatry 2013; 202:14–21 Ayerbe L et al. The natural history of depression up to 15 years after stroke: the South London Stroke Register. Stroke 2013; 44:1105–1110 Pan A et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011; 306:1241–1249 Dong JY et al. Depression and risk of stroke: a meta-analysis of prospective studies. Stroke 2012; 43:32–37 Whooley MA Depression and cardiovascular disease: healing the broken-hearted. JAMA 2006; 295:2874–2881 Otte C et al. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study. Biol Psychiatry 2004; 56:241–247 O’donnell MJ et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010; 376:112–123 Neu P [Correlation of depression with stroke. Pathophysiological mechanisms]. Nervenarzt 2009; 80:772, 774-776, 778–780 Holsboer F et al. Stress hormone regulation: biological role and translation into therapy. Annu Rev Psychol 2010; 61:81–109, C101-111 Lederbogen F et al. Effect of mental and physical stress on platelet activation markers in depressed patients and healthy subjects: a pilot study. Psychiatry Res 2004; 127:55–64 Duivis HE et al. Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 2011; 168:913–920 Miller AH et al. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65:732–741 Otte C et al. Depressive symptoms and 24- hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. Am J Psychiatry 2005; 162:2139–2145 Schweiger U et al. Disturbed glucose disposal in patients with major depression; application of the glucose clamp technique. Psychosom Med 2008; 70:170–176 El Husseini N et al. The role of neuroendocrine pathways in prognosis after stroke. Expert review of neurotherapeutics 2014; 14:217–232 Whooley MA et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300:2379–2388 Win S et al. Depressive symptoms, physical inactivity and risk of cardiovascular mortality in older adults: the Cardiovascular Health Study. Heart 2011; 97:500–505 Gehi A et al. Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med 2005; 165:2508–2513 Thorndike AN et al. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch Intern Med 2008; 168:186–191 Carson AJ et al. Depression after stroke and lesion location: a systematic review. Lancet 2000; 356:122–126 Kronenberg G et al. Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biol Psychiatry 2012; 72:273–281 Santos M et al. The neuroanatomical model of post-stroke depression: towards a change of focus? J Neurol Sci 2009; 283:158–162 Swardfager W et al. Interleukin-17 in poststroke neurodegeneration. Neurosci Biobehav Rev 2013; 37:436–447 Yang L et al. The serum interleukin-18 is a potential marker for development of poststroke depression. Neurological research 2010; 32:340–346 Fang J et al. Etiological mechanisms of post-stroke depression: a review. Neurological research 2009; 31:904–909 Dantzer R Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001; 933:222–234 Del Zoppo GJ et al. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007; 38:646–651 Hellmann-Regen J et al. Accelerated degradation of retinoic acid by activated microglia. J Neuroimmunol 2013; 256:1–6 Yrjanheikki J et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 1998; 95:15769–15774 Franco EC et al. Modulation of microglial activation enhances neuroprotection and functional recovery derived from bone marrow mononuclear cell transplantation after cortical ischemia. Neuroscience research 2012; 73:122–132 Li L et al. The effects of retinoic acid on the expression of neurogranin after experimental cerebral ischemia. Brain research 2008; 1226:234–240 Hackett ML et al. Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 2005; 36:1098–1103 Boden-Albala B et al. Social isolation and outcomes post stroke. Neurology 2005; 64:1888–1892 Berg A et al. Assessment of depression after stroke: a comparison of different screening instruments. Stroke 2009; 40:523–529 Nolte CH et al. [Two simple questions to diagnose post-stroke depression]. Fortschritte der Neurologie-Psychiatrie 2006; 74:251–256 Whooley MA et al. Case-finding instruments for depression. Two questions are as good as many. Journal of general internal medicine 1997; 12:439–445 Suija K et al. Validation of the Whooley questions and the Beck Depression Inventory in older adults. Scandinavian journal of primary health care 2012; 30:259–264 Allan LM et al. Long-term incidence of depression and predictors of depressive symptoms in older stroke survivors. Br J Psychiatry 2013; 203:453–460 De Man-Van Ginkel JM et al. In-hospital risk prediction for post-stroke depression: development and validation of the Post-stroke Depression Prediction Scale. Stroke 2013; 44:2441–2445 Hackett ML et al. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008:CD003437 Mitchell PH et al. Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke 2009; 40:3073–3078 Robinson RG et al. Escitalopram and problem- solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008; 299:2391–2400 Harter M et al. [Evidence-based therapy of depression: S3 guidelines on unipolar depression]. Nervenarzt 2010; 81:1049–1068 Marcum ZA et al. FDA drug safety communications: a narrative review and clinical considerations for older adults. Am J Geriatr Pharmacother 2012; 10:264–271 Hackam DG et al. Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 2012; 79:1862–1865 Nelva A et al. [Hemorrhagic syndromes related to selective serotonin reuptake inhibitor (SSRI) antidepressants. Seven case reports and review of the literature]. Rev Med Interne 2000; 21:152–160 Targownik LE et al. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 2009; 104:1475–1482 Leung M et al. Fluvoxamine-associated bleeding. Can J Psychiatry 1996; 41:604–605 Andrade C et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010; 71:1565–1575 Castro VM et al. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. BMJ open 2012; 2:e000544 De Abajo FJ et al. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol 2006; 98:304–310 Lee YC et al. Antidepressant use and the risk of upper gastrointestinal bleeding in psychiatric patients: a nationwide cohort study in Taiwan. J Clin Psychopharmacol 2012; 32:518–524 Niedermaier N et al. Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry 2004; 65:1619–1623 Andrade C Drug interactions in the treatment of depression in patients with ischemic heart disease. J Clin Psychiatry 2012; 73:e1475–1477 Mead GE et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev 2012; 11:CD009286 Chollet F et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011; 10:123-130 Pariente J et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001; 50:718–729 Hackett ML et al. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2008:CD003689 Salter KL et al. Prevention of Poststroke Depression: Does Prophylactic Pharmacotherapy Work? J Stroke Cerebrovasc Dis 2012 Dam M et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27:1211–1214 Li WL et al. Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke. Journal of neuroscience research 2009; 87:112–122 Lim CM et al. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. Journal of neuroscience research 2009; 87:1037–1045 Windle V et al. Fluoxetine and recovery of motor function after focal ischemia in rats. Brain research 2005; 1044:25–32